BioCentury
ARTICLE | Company News

Dainippon Sumitomo sales and marketing update

September 24, 2012 7:00 AM UTC

Dainippon's Sunovion Pharmaceuticals Canada Inc. subsidiary launched once-daily Latuda lurasidone in Canada to treat acute schizophrenia in adults. Latuda is available in 40, 80 and 120 mg tablets. H...